Clinicopathologic Features of Patients with Serum Prostate-Specific Antigen Levels > 1000 ng/mL

被引：0
|
作者：
Horwath, Michael [1 ]
Oprea-Ilies, Gabriela [2 ]
Osunkoya, Adeboye [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] Emory Univ, Sch Med, Grady Mem Hosp, Atlanta, GA USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
767
引用
收藏
页码：S962 / S963
页数：2
相关论文
共 50 条
  • [1] The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10 ng/ml
    Akdas, A
    Tarcan, T
    Turkeri, L
    Cevik, I
    Biren, T
    Ilker, Y
    [J]. EUROPEAN UROLOGY, 1996, 29 (02) : 189 - 192
  • [2] Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels <10 ng/mL -: The "PSA negative" patients
    Birtle, AJ
    Freeman, A
    Masters, JRW
    Payne, HA
    Harland, SJ
    [J]. CANCER, 2003, 98 (11) : 2362 - 2367
  • [3] The Effect of Antibiotherapy on Prostate-Specific Antigen Levels and Prostate Biopsy Results in Patients with Levels 2.5 to 10 ng/mL
    Toktas, Gokhan
    Demiray, Murat
    Erkan, Erkan
    Kocaaslan, Ramazan
    Yucetas, Ugur
    Unluer, Suleyman Erdinc
    [J]. JOURNAL OF ENDOUROLOGY, 2013, 27 (08) : 1061 - 1067
  • [4] Diagnostic efficacy of free prostate-specific antigen/total prostate-specific antigen ratio for the diagnosis of prostate cancer in low concentration (≤4 ng/ml) and intermediate levels of total prostate-specific antigen (4.01-10.0 ng/ml)
    Caliskan, Selahattin
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (02) : 279 - 283
  • [5] Serum ribonuclease activity in the diagnosis of prostate cancer in men with serum prostate-specific antigen levels between 2.5 and 20 ng/mL
    Eskicorapci, SY
    Özkara, HA
    Önder, E
    Akdogan, B
    Erkan, I
    Ciliv, G
    Ozen, H
    [J]. CLINICAL BIOCHEMISTRY, 2006, 39 (04) : 363 - 366
  • [6] Comparison among different precursor prostate-specific antigen isoform derivatives on prostate cancer prediction in patients with serum prostate-specific antigen bellow 10 ng/ml
    Stojadinovic, Milorad M.
    Pantic, Damnjan N.
    Andjelkovic, Marija, V
    Stojadinovic, Miroslav M.
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2020, 148 (3-4) : 160 - 166
  • [7] The Clinical Course of Patients With Prostate-Specific Antigen ≥100 ng/ml: Insight Into a Potential Population for Targeted Prostate-Specific Antigen Screening
    Leung, Andrew K.
    Hugar, Lee
    Patil, Dattatraya
    Wong, Lisa
    Carthon, Bradley
    Carney, K. Jeff
    Birdsong, George, II
    Moses, Kelvin A.
    Master, Viraj A.
    [J]. UROLOGY, 2018, 117 : 101 - 106
  • [8] Radical prostatectomy for prostate cancer patients with prostate-specific antigen >20 ng/ml
    Ou, YC
    Chen, JT
    Cheng, CL
    Ho, HC
    Yang, CR
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (11) : 574 - 579
  • [9] Diagnostic efficacy of free to total ratio of prostate-specific antigen and prostate-specific antigen velocity, singly and in combination, in detecting prostate cancer in patients with total serum prostate-specific antigen between 4 and 10 ng/ml
    Shingo Yamamoto
    Takuo Maruyama
    Nobuyuki Kondoh
    Michio Nojima
    Hidekazu Takiuchi
    Seiichi Hirota
    Hiroki Shima
    [J]. International Urology and Nephrology, 2008, 40 : 85 - 89
  • [10] Diagnostic efficacy of free to total ratio of prostate-specific antigen and prostate-specific antigen velocity, singly and in combination, in detecting prostate cancer in patients with total serum prostate-specific antigen between 4 and 10 ng/ml
    Yamamoto, Shingo
    Maruyama, Takuo
    Kondoh, Nobuyuki
    Nojima, Michio
    Takiuchi, Hidekazu
    Hirota, Seiichi
    Shima, Hiroki
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (01) : 85 - 89
12345